SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : EXTI - only public co. developing liver device -- Ignore unavailable to you. Want to Upgrade?

To: LesX who wrote (164)1/27/1998 10:42:00 PM
From: MaxLeverage  Respond to of 1063
 
LesX,

Thank's for the report. It's much appreciated.

Rich

Let the waiting continue..



To: LesX who wrote (164)2/4/1998 4:55:00 AM
From: CENTrader  Respond to of 1063
 
LesX,

Great Report.....Thank You. Please continue to keep us informed.

I especially like this part....

"The advantage to the Xenogenic machine is that it extends the life of the pig cells; hence, creating a cost savings on the order of 20:1 when compared to similar processes that have a problem keeping the cells alive. "

This is the kind of info we can really "hang our hats on!" This is the "meat & potatoes!"

Thanks again,

Bill



To: LesX who wrote (164)2/28/1998 2:24:00 AM
From: CENTrader  Read Replies (2) | Respond to of 1063
 
Hey LesX,

Don't you think it's about time you had another talk with Gerry!?
Would love to know how close they are to funding & patent approval.

Notice the new moniker, SybiolR on their website.

Good Investing,

Bill


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News